September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Cholinergic regulation of dendritic cell uptake and immune response to topically applied antigens to the conjunctiva
Author Affiliations & Notes
  • Stephen C Pflugfelder
    Ophthalmology, Baylor College of Medicine, Houston, Texas, United States
  • Cintia S De Paiva
    Ophthalmology, Baylor College of Medicine, Houston, Texas, United States
  • Terry G Coursey
    Ophthalmology, Baylor College of Medicine, Houston, Texas, United States
  • Flavia L Barbosa
    Ophthalmology, Baylor College of Medicine, Houston, Texas, United States
  • Footnotes
    Commercial Relationships   Stephen Pflugfelder, None; Cintia De Paiva, None; Terry Coursey, None; Flavia Barbosa, None
  • Footnotes
    Support  Biology of Inflammation/Baylor College of Medicine (SCP), Supported by NIH EY11915, NEI/NIH Core Grant EY-002520, Research to Prevent Blindness, The Oshman Foundation, William Stamps Farish Fund and the Hamill Foundation.
Investigative Ophthalmology & Visual Science September 2016, Vol.57, No Pagination Specified. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Stephen C Pflugfelder, Cintia S De Paiva, Terry G Coursey, Flavia L Barbosa; Cholinergic regulation of dendritic cell uptake and immune response to topically applied antigens to the conjunctiva. Invest. Ophthalmol. Vis. Sci. 201657(12):.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To evaluate the effects of cholinergic stimulation/blockade on distribution, dendritic cell (DC) uptake and immune response to antigen (Ag) applied to the mouse conjunctiva.

Methods : Experiments were performed in 8-week old female C57/BL6 (B6) mice without and with pre-topical cholinergic stimulation with carbachol (CCh) or blockade with scopolamine (Scop). Distribution and DC uptake of topically applied FITC-labeled 2.3 kDA OVA323-339 peptide was evaluated by confocal microscopy in whole mount conjunctiva labeled with mucin or DC markers. OVA+ DCs were detected in the cervical lymph nodes (CLN) by flow cytometry 24 hr after topical instillation and compared to water controls. Proliferative response to topically applied OVA peptide (daily x 3 days) in the CLNs of OT-II (H-2b) transgenic mice was evaluated by WST assay.

Results : CCh stimulation prior to topical OVA peptide application increased epithelial mucin binding. In contrast, cholinergic blockade with Scop caused diffuse paracellular antigen migration into the stroma. There were few OVA+CD11c+ or OVA+CD11b+ DCs in the epithelium or stroma under homeostatic conditions. After CCh stimulation, weakly OVA+ CD11c+ and OVA+CD11b+ cells were noted in the superficial stroma. Following Scop, strongly OVA+ CD11c+ and CD11b+ cells were present in the epithelium and stroma. In the cervical nodes, OVA+CD11c+ cells were non detectable in the water and OVA peptide groups and detectable in a low percentage of cells in the other groups (CCh+OVA = 0.04%, Scop+OVA = 0.1%). A greater percentage of OVA+CD11b+ cells were found in all groups, ranging from 0.11 (OVA) to 0.32 (Scop+OVA), with no statistical difference between groups. The percentage OVA+CD11b+CD11c+ cells was greater in the Scop+OVA group than the OVA and CCh+OVA groups (P ≤ 0.05). The number of proliferating cells in the CLNs following topical Ag challenge was lower in the OVA and CCh+OVA groups than the water control, while there was significantly higher proliferation (P ≤ 0.05) in the Scop+OVA than the other groups.

Conclusions : Cholinergic tone promotes immune tolerance, perhaps through antigen binding to ocular surface mucins that reduces DC antigen uptake. Cholinergic blockade increases the number of antigen positive cells and antigen specific immune response in the draining nodes.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×